Compare INTS & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTS | UPLD |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 12.8M |
| IPO Year | 2021 | 2014 |
| Metric | INTS | UPLD |
|---|---|---|
| Price | $4.04 | $5.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $38.00 | $3.75 |
| AVG Volume (30 Days) | 25.0K | ★ 26.0K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.38 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $74,767,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.95 |
| 52 Week Low | $0.22 | $0.50 |
| 52 Week High | $8.06 | $6.65 |
| Indicator | INTS | UPLD |
|---|---|---|
| Relative Strength Index (RSI) | 41.36 | 55.63 |
| Support Level | $3.99 | $4.01 |
| Resistance Level | $5.00 | $5.65 |
| Average True Range (ATR) | 0.28 | 0.60 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 23.74 | 50.00 |
Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.